Senzime AB (publ) announced that the company has contracted Erik Bergman as new CFO and member of the management team. Erik succeeds Jessica Roxhed as CFO and takes office on October 1, 2019. Erik comes from a position as CEO of the vaccine adjuvant company Novavax AB, and since autumn 2018 he has worked at Senzime to a lesser extent via his own company.